#Startup behind Oxford COVID vaccine reportedly eyes IPO

#Startup behind Oxford COVID vaccine reportedly eyes IPO

“#Startup behind Oxford COVID vaccine reportedly eyes IPO” A startup that played a crucial role in developing Oxford University’s coronavirus vaccine is hatching plans to go public — but the centuries-old school may be standing in the way, a new report says. The startup, Vaccitech, was founded in 2016 by two Oxford scientists who created…

Read More
#Moderna confident COVID-19 vaccine will work against new strain

#Moderna confident COVID-19 vaccine will work against new strain

“#Moderna confident COVID-19 vaccine will work against new strain” Moderna says it’s confident that its COVID-19 vaccine will provide protection from the highly contagious coronavirus strain that’s spreading in the UK and other countries. Research has shown the shot is “equally effective” against several other variants of the virus that emerged earlier in the pandemic,…

Read More
#FDA finds Moderna’s COVID-19 vaccine to be safe, 94% effective

#FDA finds Moderna’s COVID-19 vaccine to be safe, 94% effective

“#FDA finds Moderna’s COVID-19 vaccine to be safe, 94% effective” The Food and Drug Administration found Moderna’s coronavirus vaccine to be safe and highly effective, bolstering the shot’s chances of being cleared for emergency use this week. In a 54-page report released Tuesday, FDA staff affirmed the Massachusetts biotech firm’s finding that the vaccine is about 94 percent effective…

Read More
#Clover Health set to go public through blank-check company

#Clover Health set to go public through blank-check company

“#Clover Health set to go public through blank-check company” Clover Health, a Medicare-focused insurance startup based in Jersey City, NJ, said Tuesday it will go public after merging with the latest blank-check company from Silicon Valley investor Chamath Palihapitiya. Clover, which has more than 57,000 members in seven states, will be valued at $3.7 billion….

Read More